Medizinische Universit├Ąt Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Bartsch, R; Gampenrieder, SP; Rinnerthaler, G; Petru, E; Egle, D; Petzer, A; Balic, M; Pluschnig, U; Sliwa, T; Singer, C.
Updated Austrian treatment algorithm in HER2+metastatic breast cancer
WIEN KLIN WOCHENSCHR. 2022; 134(1-2): 63-72. Doi: 10.1007/s00508-021-01987-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Co-authors Med Uni Graz
Balic Marija
Petru Edgar

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

A group of Austrian breast cancer specialists met in December 2020 to establish a comprehensive clinical benefit-risk profile of available HER2-targeted therapies based on recent data and to develop an updated treatment algorithm by consensus over several months in 2021. A total of four scenarios were developed in which treatment strategies appropriate for specific patient profiles were evaluated. Consensus was established by detailed discussions of each scenario and by reaching full consensus.

Find related publications in this database (Keywords)
Tyrosin-kinase inhibitor
© Med Uni GrazImprint